#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?
Breakpoints
00:00
Cabotage for PrEP: The Pharmacokinetic Tail and Resistance Development
Cabotage for PrEP is much more effective than I expected it to be. It's just starting PrEP with Cabotegravir is still a rarity, at least in our clinic. So we're using way more Cabropivarine than we are Caboteg Gravir. We did the Cabotagavirinibilizumab but I think that if I had to do it again, I probably would leave the Ibalizumab all.
Transcript
Play full episode
